Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
June 2025
For example, some people find that they eat less on a GLP-1, but theyre not improving their health because theyre not exercising
To find the proportion of ESI enrollees with a prescription for GLP-1 drugs, outpatient pharmaceutical claims from 2012 to 2022 in the Merative MarketScan Commercial Database were used
Market Segmentation Drug Class Insights (Revenue, USD Bn, 2021 - 2033) Exenatide Liraglutide Dulaglutide Lixisenatide Albiglutide Semaglutide Route of Administration Insights (Revenue, USD Bn, 2021 - 2033) Parenteral Oral Application Insights (Revenue, USD Bn, 2021 - 2033) Type 2 Diabetes Mellitus Obesity Liver Cirrhosis Non-alcoholic Steatohepatitis Others Distribution Channel Insights (Revenue, USD Bn, 2021 - 2033) Hospital Pharmacies Retail Pharmacies Online Pharmacies Regional Insights (Revenue, USD Bn, 2021 - 2033) North America U.S
US$ 29.09
US$ 27.72
US$ 24.33
US$ 27.16
US$ 23.50
US$ 27.75
